Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: A phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group)

被引：0
|
作者：
McGuire, WP
Hoskins, WJ
Brady, MF
Kucera, PR
Partridge, EE
Look, KY
ClarkePearson, DL
Davidson, M
机构：
[1] EMORY UNIV, DEPT MED, ATLANTA, GA 30322 USA
[2] MEM SLOAN KETTERING CANC CTR, DEPT SURG, GYNECOL SERV, NEW YORK, NY 10021 USA
[3] CORNELL UNIV, COLL MED, DEPT OBSTET & GYNECOL, NEW YORK, NY USA
[4] ROSWELL PK CANC INST, GYNECOL ONCOL GRP, STAT OFF, BUFFALO, NY USA
[5] OREGON HLTH SCI UNIV, DEPT OBSTET & GYNECOL, DIV GYNECOL ONCOL, PORTLAND, OR 97201 USA
[6] UNIV ALABAMA, DEPT OBSTET & GYNECOL, DIV GYNECOL ONCOL, BIRMINGHAM, AL 35294 USA
[7] INDIANA UNIV, SCH MED, DIV OBSTET & GYNECOL, INDIANAPOLIS, IN USA
[8] DUKE UNIV, SCH MED, DEPT OBSTET & GYNECOL, DIV GYNECOL ONCOL, DURHAM, NC 27706 USA
[9] WALTER REED ARMY MED CTR, DEPT PATHOL & AREA LAB SCI, WASHINGTON, DC 20307 USA
来源：
SEMINARS IN ONCOLOGY | 1996年 / 23卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：40 / 47
页数：8
相关论文
共 50 条
  • [31] Phase III randomized trial of doxorubicin plus cisplatin versus doxorubicin+24-h paclitaxel plus filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study
    Fleming, GF
    Filiaci, VL
    Bentley, RC
    Herzog, T
    Sorosky, J
    Vaccarello, L
    Gallion, H
    ANNALS OF ONCOLOGY, 2004, 15 (08) : 1173 - 1178
  • [32] A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A gynecologic oncology group study
    Sutton, G
    Brunetto, VL
    Kilgore, L
    Soper, JT
    McGehee, R
    Olt, G
    Lentz, SS
    Sorosky, J
    Hsiu, JG
    GYNECOLOGIC ONCOLOGY, 2000, 79 (02) : 147 - 153
  • [33] A Phase III Trial of Paclitaxel plus Carboplatin Versus Paclitaxel plus Cisplatin in Stage IVB, Persistent or Recurrent Cervical Cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505)
    Saito, Isamu
    Kitagawa, Ryo
    Fukuda, Haruhiko
    Shibata, Taro
    Katsumata, Noriyuki
    Konishi, Ikuo
    Yoshikawa, Hiroyuki
    Kamura, Toshiharu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (01) : 90 - 93
  • [34] Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group study
    Bell, Jeffrey
    Brady, Mark F.
    Young, Robert C.
    Lage, Janice
    Walker, Joan L.
    Look, Katherine Y.
    Rose, G. Scott
    Spirtos, Nick M.
    GYNECOLOGIC ONCOLOGY, 2006, 102 (03) : 432 - 439
  • [35] COMPARISON OF CYCLOPHOSPHAMIDE PLUS CISPLATIN VERSUS HEXAMETHYLMELAMINE, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN IN COMBINATION AS INITIAL CHEMOTHERAPY FOR STAGE-III AND STAGE-IV OVARIAN CARCINOMAS
    EDMONSON, JH
    MCCORMACK, GW
    FLEMING, TR
    CULLINAN, SA
    KROOK, JE
    MALKASIAN, GD
    PODRATZ, KC
    MAILLIARD, JA
    JEFFERIES, JA
    BARLOW, JF
    WINDSCHITL, HE
    CANCER TREATMENT REPORTS, 1985, 69 (11): : 1243 - 1248
  • [36] A Gynecologic Oncology Group phase III randomized trial of weekly cisplatin and radiation versus cisplatin and tirapazamine and radiation in stage IB2, IIA, IIIB and IVA cervical carcinoma limited to the pelvis
    DiSilvestro, P.
    Ali, S.
    Peter, C.
    Spirtos, N.
    Lucci, J.
    Lee, Y.
    Cohn, D.
    Tewari, K.
    Muller, C.
    Steinhoff, M.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S3 - S4
  • [37] Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer
    Lara, Primo N., Jr.
    Gandara, David R.
    Natale, Ronald B.
    CLINICAL LUNG CANCER, 2006, 7 (05) : 353 - 356
  • [38] Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group trial
    Markman, M
    Liu, PY
    Wilczynski, S
    Monk, B
    Copeland, LJ
    Alvarez, RD
    Jiang, C
    Alberts, D
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (13) : 2460 - 2465
  • [39] Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): An intergroup trial of the eastern cooperative oncology group
    Gibson, MK
    Li, Y
    Murphy, B
    Hussain, MHA
    DeConti, RC
    Ensley, J
    Forastiere, AA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3562 - 3567
  • [40] Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: The Japanese taxotere lung cancer study group
    Kubota, K
    Watanabe, K
    Kunitoh, H
    Noda, K
    Ichinose, Y
    Katakami, N
    Sugiura, T
    Kawahara, M
    Yokoyama, A
    Yokota, S
    Yoneda, S
    Matsui, K
    Kudo, S
    Shibuya, M
    Isobe, T
    Segawa, Y
    Nishiwaki, Y
    Ohashi, Y
    Niitani, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) : 254 - 261
12345